List of Excipients in API atorvaliq
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing atorvaliq
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
CMP Pharma Inc | ATORVALIQ | atorvaliq | 46287-030 | ACESULFAME POTASSIUM | |
CMP Pharma Inc | ATORVALIQ | atorvaliq | 46287-030 | CARBOXYMETHYLCELLULOSE SODIUM | |
CMP Pharma Inc | ATORVALIQ | atorvaliq | 46287-030 | ETHYLPARABEN | |
CMP Pharma Inc | ATORVALIQ | atorvaliq | 46287-030 | MAGNESIUM ALUMINUM SILICATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for atorvaliq
Excipient focus: ACESULFAME POTASSIUM
atorvaliq drug variants containing ACESULFAME POTASSIUM
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing ACESULFAME POTASSIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
atorvaliq drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLPARABEN
atorvaliq drug variants containing ETHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing ETHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
atorvaliq drug variants containing MAGNESIUM ALUMINUM SILICATE
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing MAGNESIUM ALUMINUM SILICATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
atorvaliq drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
atorvaliq drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
atorvaliq drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
atorvaliq drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
CMP Pharma Inc | atorvaliq | 46287-030 |
>Company | >Ingredient | >NDC |
atorvaliq drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.